You are here

Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults

-PDUFA action date set for August 19, 2019- -PDUFA action date set for August 19, 2019-
Tuesday, February 19, 2019 - 07:00